This increase in PD-1 expression is also apparent across diverse molecular B-ALL subtypes in human B-ALL samples, although in mouse and human leukemias PD-1 expression is not solely dependent on PAX5 activity, and further studies should help to identify the mechanisms involved. This evidence concerns the gene PAX5 and acute lymphoblastic leukemia.